Talk:Perfluoro tert-butylcyclohexane

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Low	This article has been rated as Low-importance on the project's importance scale.

Advertising?

This article is flagged with an "ADVERTISING" tag. Can somebody state speifically which language reads as advertising? I contributed to this article, and pride myself on neutral writing. Please help. Lexein (talk) 17:39, 6 May 2019 (UTC)[reply]

Two Problems

This page (https://adisinsight.springer.com/drugs/800016741) has made me think of two possible issues with this article.

First: I've noticed that most articles for medicinal drugs use the generic name rather than the brand name(ex: the article for the drug "Lexapro" is titled Escitalopram). The linked page seems to give Oxycyte the generic name Perfluorocarbon Oxygen Carrier, and some other articles I've seen about Oxycyte put a ® symbol next to the name. This makes me wonder if Oxycyte is the appropriate title for this article.

Second: The page I linked lists the health issues that Oxycyte has been investigated as a treatment for, either currently or in the past. Research for this drug has been discontinued for nine different health issues, and the only remaining one, stroke, has not seen any updates since 2019. Does anyone know what the current status of this drug is, and if it's still being considered for the market? Doctor Astrocyte (talk) 07:31, 25 June 2022 (UTC) — Preceding unsigned comment added by Doctor Astrocyte (talk • contribs) 06:44, 25 June 2022 (UTC)[reply]